4.5 Review

Databases in the Area of Pharmacogenetics

期刊

HUMAN MUTATION
卷 32, 期 5, 页码 526-531

出版社

WILEY
DOI: 10.1002/humu.21454

关键词

pharmacogenetics; database; personalized medicine; adverse drug reaction; cytochrome P450; transporter; polymorphism

资金

  1. Swedish Research Council
  2. Swedish Brain Foundation
  3. Swedish Cancer Fund
  4. NIH [GM61374]

向作者/读者索取更多资源

In the area of pharmacogenetics and personalized health care it is obvious that databases, providing important information of the occurrence and consequences of variant genes encoding drug metabolizing enzymes, drug transporters, drug targets, and other proteins of importance for drug response or toxicity, are of critical value for scientists, physicians, and industry. The primary outcome of the pharmacogenomic field is the identification of biomarkers that can predict drug toxicity and drug response, thereby individualizing and improving drug treatment of patients. The drug in question and the polymorphic gene exerting the impact are the main issues to be searched for in the databases. Here, we review the databases that provide useful information in this respect, of benefit for the development of the pharmacogenomic field. Hum Mutat 32:526-531, 2011. (C) 2011 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据